Insmed (INSM) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $95.80 -2.69%
EPS Growth %: +52.9%
Financial Fact:
Net loss attributable to common stockholders: -37.76M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +52.9%
Financial Fact:
Net loss attributable to common stockholders: -37.76M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q1 EPS of ($0.96), $0.01 worse than the analyst estimate of ($0.95). Revenue for the quarter came in at $21.9 million versus the consensus estimate of $19.62 million.
The Company now expects full-year 2019 revenues for ARIKAYCE to be in the range of $90 million to $105 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Insmed (INSM) PT Lowered to $192 at Mizuho
- Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance
- Citi sees this stock as primary lithium demand beneficiary, upgrades to Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
